February 26, 2013 Press Release Mitsubishi Tanabe Pharma Corporation TENELIA® 20mg tablets, a Treatment for Type 2 Diabetes Mellitus Application for Partial Change in Indications for Combination Therapy

First Page		Document Content
Date: 2013-12-11 23:08:01 Health Anti-diabetic medication Biguanide Alpha-glucosidase inhibitor Dipeptidyl peptidase-4 inhibitor Hypoglycemia Insulin Diabetes Endocrine system Medicine		February 26, 2013 Press Release Mitsubishi Tanabe Pharma Corporation TENELIA® 20mg tablets, a Treatment for Type 2 Diabetes Mellitus Application for Partial Change in Indications for Combination Therapy Add to Reading List Source URL: www.mt-pharma.co.jp Download Document from Source Website File Size: 52,48 KB Share Document on Facebook

	PRECOSE® is therapeutically desired. Following oral dosing of healthy volunteers with 14C-labeled acarbose, peak plasma concentrations of radioactivity were (acarbose tablets) attained 14–24 hours after dosing, while DocID: 15gGi - View Document
	440 PRIMARY CARE DIABETOLOGY Initiating oral anti diabetic drug: alternatives to metformin Sanjay Kalra,1 Yashdeep Gupta2 DocID: 118aS - View Document
	Indian Journal of Biotechnology Vol 7, January 2008, pp[removed]Evaluation of α- and β-glucosidase inhibitory properties of macro-algae using intestinal extracts of marine snail, Thais rudolphi (Lamarck, 1822) V S Pramit DocID: O8j9 - View Document
	PRECOSE® is therapeutically desired. Following oral dosing of healthy volunteers with 14C-labeled acarbose, peak plasma concentrations of radioactivity were (acarbose tablets) attained 14–24 hours after dosing, while DocID: NoQt - View Document
	Type 2 Diabetes Medications: Alpha-Glucosidase Inhibitors One class of diabetes medications are the alpha-glucosidase (AL-fa-glooKOH-sih-days) inhibitors. How Do Alpha-Gulcosidase Inhibitors Work? Alpha-glucosidase inhib DocID: M5UZ - View Document